The technology is still some ways off. While the first device would use parts that were already FDA-approved, it hasn’t been tested in humans. The second, meanwhile, uses a new sensor type that will likely require more work to be testable with humans. Scientists have filed patents for both devices and are hoping to work with companies on further development. There’s a strong motivation to bring these devices to market, at least. People with diabetes would only need to use one device at meals, and with the hybrid sensor/needle might suffer less pain. That, in turn, could encourage consistent treatment that improves your overall wellbeing.
Read more of this story at Slashdot.